Ramius Advisors’s American Oncology Network, Inc. Warrant AONCW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-155,842
Closed -$15.3K 38
2023
Q1
$15.3K Sell
155,842
-17,794
-10% -$1.21K 0.02% 27
2022
Q4
$10.4K Sell
173,636
-43,842
-20% -$3.59K 0.01% 56
2022
Q3
$15K Hold
217,478
0.01% 96
2022
Q2
$60K Buy
+217,478
New +$48K 0.03% 55
2022
Q1
Sell
-210,603
Closed -$139K 127
2021
Q4
$139K Buy
210,603
+137,207
+187% +$92K 0.05% 203
2021
Q3
$50K Buy
73,396
+13,600
+23% +$10.9K 0.03% 171
2021
Q2
$56K Buy
+59,796
New +$47.7K 0.02% 240

Other funds holding AONCW

Ramius Advisors's AONCW Position: Q2 2023 in Review

Ramius Advisors sold out of American Oncology Network, Inc. Warrant (AONCW) in Q2 2023, closing a stake of 155,842 shares — an estimated $15.3K sold.

Ramius Advisors first reported a position in AONCW in Q2 2021 and held it in 7 quarters. The position peaked at $139K in Q4 2021. 46 funds tracked by Wall St. Rank hold AONCW as of Q2 2023.

  • Ramius Advisors reported no remaining American Oncology Network, Inc. Warrant position as of Q2 2023 after selling out during the quarter.
  • Ramius Advisors sold 155,842 American Oncology Network, Inc. Warrant shares in Q2 2023, an estimated $15.3K.
  • Ramius Advisors first reported a position in American Oncology Network, Inc. Warrant in Q2 2021 and held it in 7 quarters.
  • Ramius Advisors's American Oncology Network, Inc. Warrant position peaked at $139K in Q4 2021.
  • 46 funds tracked by Wall St. Rank held American Oncology Network, Inc. Warrant as of Q2 2023.

Based on Ramius Advisors's 13F filing for Q2 2023.